ABEO

Abeona Therapeut

• TipRanks·2d ago

  Insider Shake-Up: Abeona Therapeutics Director Quietly Cashes Out Stake

• PUBT·2d ago

  Abeona director Mark Alvino sells 6,500 shares worth $35,463

• TipRanks·4d ago

  Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum

• PUBT·05/15 21:05

  Abeona Therapeutics director Eric Crombez disposes 26,143 shares for $144,644.73

• PUBT·05/14 19:13

  Vogo announces shareholder meeting

• TipRanks·05/14 15:15

  Jefferies Remains a Buy on Abeona Therapeutics (ABEO)

• TipRanks·05/14 13:38

  Abeona Therapeutics (ABEO) Gets a Buy from Oppenheimer

• TipRanks·05/14 10:34

  H.C. Wainwright Sticks to Its Buy Rating for Abeona Therapeutics (ABEO)

• TipRanks·05/14 00:44

  Abeona Therapeutics Signals Strong Early ZEVASKYN Launch

• NASDAQ·05/13 21:01

  Abeona (ABEO) Q1 2026 Earnings Transcript

• TipRanks·05/13 16:50

  Analysts Are Bullish on These Healthcare Stocks: Abeona Therapeutics (ABEO), Protara Therapeutics (TARA)

• PUBT·05/13 15:35

  Abeona Q1 FY26 net product revenue more than doubled to $8.7 million; SG&A rises to $19.5 million

• Benzinga·05/13 13:51

  Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript

• Benzinga·05/13 13:31

  Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network

• TipRanks·05/13 12:17

  Abeona Therapeutics reports Q1 EPS (30c), consensus (39c)